Heparin Market Size

  • Report ID: 3402
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Heparin Market Size

Heparin Market size was over USD 10.94 billion in 2024 and is projected to exceed USD 18.82 billion by the end of 2037, witnessing over 4.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of heparin is evaluated at USD 11.32 billion.

The market growth is primarily driven by higher instances of cancer among the population. For instance, in 2040, the new cancer case count is anticipated to be nearly 28 million and the death toll is likely to reach around 16 million. Furthermore, the rising prevalence of coronary artery disease and venous thromboembolism is also fueling the growth of the heparin market over the forecast period.

Rising cases of accidents owing to vehicle crashes are expected to propel the market growth. As per the data of the World Health Organization, road accident is the most common cause of death of children and adults aged 5 to 29 and about 1.3 million people every year die in road accident globally. Furthermore, blood clotting during surgeries owing to several conditions also boosts the growth of the global heparin market.

 

 


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3402
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of heparin is evaluated at USD 11.32 billion.

The heparin market size was over USD 10.94 billion in 2024 and is projected to exceed USD 18.82 billion by the end of 2037, witnessing over 4.4% CAGR during the forecast period i.e., between 2025-2037. The higher number of patients with cancer, increased prevalence of chronic disease, rising cases of thromboembolism, and road accidents will boost the market growth.

North America is likely to dominate majority industry share by 2037, propelled by higher number of people developing chronic kidney diseases, followed by surging healthcare expenditure.

The major players in the market include Aspen Holdings, Opocrin S.p.A., LEO Pharma Inc., Baxter, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., B. Braun Medical Inc., Bioiberica S.A.U., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Fresenius Kabi Canada.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample